SHARE
 
Peiman Hematti, MD close
6SrNJEnsIXs
Peiman Hematti, MD
 

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Peiman Hematti, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Peiman Hematti joined the Section of Hematology/Bone Marrow Transplantation at the University of Wisconsin-Madison in July 2004 as an Assistant Professor in the Department of Medicine. Dr. Hematti has completed a combined Internal Medicine/Pediatrics residency at the Cleveland Clinic Foundation and then Hematology fellowship at the National Heart, Lung and Blood Institute at the National Institutes of Health. His clinical interests are in inpatient care of hematopoietic stem cell transplant patients. He is the director of the clinical hematopoietic cell processing laboratory, and in that capacity oversees all the peripheral blood stem cell collections from the patients and processing of their products.

Specialties

Hematology

Bone Marrow Biopsy

Bone Marrow Transplant (BMT)

CAR T-cell Therapy (Adult)

Hematology (Leukemia, Lymphoma and Multiple Myeloma)

Scleroderma

Clinics

UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Medicine
Department of Pediatrics

Professional Certifications and Education

Board Certification Hematology
Internal Medicine
Pediatrics
Fellowship National Institutes of Health, Bethesda, MD
Residency Cleveland Clinic Foundation, Cleveland, OH
Internship Cleveland Clinic Foundation, Cleveland, OH
Medical School Tehran University of Medical Sciences, Tehran, Iran

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
Research

Dr. Hematti runs an active basic research lab with the goal of developing methods for ex vivo generation and expansion of hematopoietic stem cells. His clinical research interest is in using novel mobilization agents for collection of peripheral blood stem cells.


PubMed Articles
Raval AN Johnston PV Duckers HJ Cook TD Traverse JH Altman PA Dhingra R Hematti P Borrello I Anderson RD Pepine CJ Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort. Int J Cardiol . 2021 Mar 1;326:131-138
[PubMed ID: 33091520]
Schmuck EG Roy S Dhillon A Walker S Spinali K Colevas S Zhou T Chhabra G Liu Y Kader Sagar MA Childs CJ Kink JA Eliceiri KW Hematti P Raval AN Cultured cardiac fibroblasts and myofibroblasts express Sushi Containing Domain 2 and assemble a unique fibronectin rich matrix. Exp Cell Res . 2021 Feb 15;399(2):112489
[PubMed ID: 33453237]
D'Souza SS Bennett S Kumar A Kelnhofer LE Weinfurter J Suknuntha K Coonen J Mejia A Simmons H Golos T Hematti P Capitini CM Reynolds MR Slukvin II Transplantation of T-cell receptor α/β-depleted allogeneic bone marrow in nonhuman primates. Exp Hematol . 2021 Jan;93:44-51
[PubMed ID: 33176119]
Mushtaq MU Harrington AM Chaudhary SG Michaelis LC Carlson KB Abedin S Runass L Callander NS Fallon MJ Juckett M Hall AC Hematti P Mattison RJ Atallah EL Guru Murthy GS Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia. Leuk Lymphoma . 2021 Jan;62(1):158-166
[PubMed ID: 32951486]
Chamberlain CS Kink JA Wildenauer LA McCaughey M Henry K Spiker AM Halanski MA Hematti P Vanderby R Exosome-educated macrophages and exosomes differentially improve ligament healing. Stem Cells . 2021 Jan;39(1):55-61
[PubMed ID: 33141458]
Jabbehdari S Yazdanpanah G Kanu LN Chen E Kang K Anwar KN Ghassemi M Hematti P Rosenblatt MI Djalilian AR Therapeutic Effects of Lyophilized Conditioned-Medium Derived from Corneal Mesenchymal Stromal Cells on Corneal Epithelial Wound Healing. Curr Eye Res . 2020 Dec;45(12):1490-1496
[PubMed ID: 32338541]
Roy S Spinali K Schmuck EG Kink JA Hematti P Raval AN Cardiac fibroblast derived matrix-educated macrophages express VEGF and IL-6, and recruit mesenchymal stromal cells. J Immunol Regen Med . 2020 Dec;10
[PubMed ID: 33564732]
Heninger E Sethakorn N Kosoff D Hematti P Kuczler MD Pienta KJ Lang JM Immune profiling of the bone marrow microenvironment in patients with high-risk localized prostate cancer. Oncotarget . 2020 Nov 17;11(46):4253-4265
[PubMed ID: 33245727]
Pasquini MC Hu ZH Curran K Laetsch T Locke F Rouce R Pulsipher MA Phillips CL Keating A Frigault MJ Salzberg D Jaglowski S Sasine JP Rosenthal J Ghosh M Landsburg D Margossian S Martin PL Kamdar MK Hematti P Nikiforow S Turtle C Perales MA Steinert P Horowitz MM Moskop A Pacaud L Yi L Chawla R Bleickardt E Grupp S Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma. Blood Adv . 2020 Nov 10;4(21):5414-5424
[PubMed ID: 33147337]
Carlson K Kink J Hematti P Al-Adra DP Extracellular Vesicles as a Novel Therapeutic Option in Liver Transplantation. Liver Transpl . 2020 Nov;26(11):1522-1531
[PubMed ID: 32844568]
Hess NJ Lindner PN Vazquez J Grindel S Hudson AW Stanic AK Ikeda A Hematti P Gumperz JE Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source. Front Immunol . 2020;11:573406
[PubMed ID: 33193358]
Solomon SR Martin AS Zhang MJ Ballen K Bashey A Battiwalla M Baxter-Lowe LA Brunstein C Chhabra S Perez MAD Fuchs EJ Ganguly S Hardy N Hematti P McGuirk J Peres E Ringden O Rizzieri D Romee R Solh M Szwajcer D van der Poel M Waller E William BM Eapen M Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant. Biol Blood Marrow Transplant . 2020 Oct;26(10):1930-1936
[PubMed ID: 32649981]
Chinnadurai R Forsberg MH Kink JA Hematti P Capitini CM Use of MSCs and MSC-educated macrophages to mitigate hematopoietic acute radiation syndrome. Curr Stem Cell Rep . 2020 Sep;6(3):77-85
[PubMed ID: 32944493]
D'Angelo CR Hall A Woo KM Kim K Longo W Hematti P Callander N Kenkre VP Mattison R Juckett M Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications. Leuk Res . 2020 Sep;96:106419
[PubMed ID: 32683127]
Weishar R Lee MS Fontana G Hematti P Li WJ Endothelin-1 reduces catabolic activity of human mesenchymal stem/stromal cells during chondro- and osteo-lineage differentiation. Biochem Biophys Res Commun . 2020 Aug 20;529(2):180-185
[PubMed ID: 32703408]
Im A Rashidi A Wang T Hemmer M MacMillan ML Pidala J Jagasia M Pavletic S Majhail NS Weisdorf D Abdel-Azim H Agrawal V Al-Homsi AS Aljurf M Askar M Auletta JJ Bashey A Beitinjaneh A Bhatt VR Byrne M Cahn JY Cairo M Castillo P Cerny J Chhabra S Choe H Ciurea S Daly A Perez MAD Farhadfar N Gadalla SM Gale R Ganguly S Gergis U Hanna R Hematti P Herzig R Hildebrandt GC Lad DP Lee C Lehmann L Lekakis L Kamble RT Kharfan-Dabaja MA Khandelwal P Martino R Murthy HS Nishihori T O'Brien TA Olsson RF Patel SS Perales MA Prestidge T Qayed M Romee R Schoemans H Seo S Sharma A Solh M Strair R Teshima T Urbano-Ispizua A Van der Poel M Vij R Wagner JL William B Wirk B Yared JA Spellman SR Arora M Hamilton BK Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. Biol Blood Marrow Transplant . 2020 Aug;26(8):1459-1468
[PubMed ID: 32434056]
Forsberg MH Kink JA Hematti P Capitini CM Mesenchymal Stromal Cells and Exosomes: Progress and Challenges. Front Cell Dev Biol . 2020;8:665
[PubMed ID: 32766255]
Frigault MJ Nikiforow S Mansour MK Hu ZH Horowitz MM Riches ML Hematti P Turtle CJ Zhang MJ Perales MA Pasquini MC Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19? Blood . 2020 Jul 2;136(1):137-139
[PubMed ID: 32457999]
Hess NJ Hudson AW Hematti P Gumperz JE Early T Cell Activation Metrics Predict Graft-versus-Host Disease in a Humanized Mouse Model of Hematopoietic Stem Cell Transplantation. J Immunol . 2020 Jul 1;205(1):272-281
[PubMed ID: 32444392]
Liao R Zheng Y Liu X Zhang Y Seim G Tanimura N Wilson GM Hematti P Coon JJ Fan J Xu J Keles S Bresnick EH Discovering How Heme Controls Genome Function Through Heme-omics. Cell Rep . 2020 Jun 30;31(13):107832
[PubMed ID: 32610133]